F2 and Stroke: Prothrombin mutation was associated with significantly increased stroke risk in adults ≤55 years (OR=1.4; 95% CI=1.1-1.9; P=0.02), with significance increasing with the addition of the GEOS results (OR=1.5; 95% CI=1.1-2.0; P=0.005)